High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes-Reference-Cited by-同舟云学术

High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes

Published:2020-04-01 Issue:4 Volume:6 Page:528
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Steenbruggen Tessa G.¹,Steggink Lars C.²,Seynaeve Caroline M.³,van der Hoeven Jacobus J. M.⁴,Hooning Maartje J.³,Jager Agnes³,Konings Inge R.⁵,Kroep Judith R.⁶,Smit Wim M.⁷,Tjan-Heijnen Vivianne C. G.⁸,van der Wall Elsken⁹,Bins Adriaan D.¹⁰,Linn Sabine C.¹,Schaapveld Michael¹¹,Jacobse Judy N.¹¹,van Leeuwen Flora E.¹¹,Schröder Carolien P.²,van Tinteren Harm¹²,de Vries Elisabeth G. E.²,Sonke Gabe S.¹,Gietema Jourik A.²

Affiliation:

1. Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands

2. Department of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands

3. Department of Medical Oncology, Erasmus MC University Medical Center, Rotterdam, the Netherlands

4. Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands

5. Department of Medical Oncology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands

6. Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands

7. Department of Internal Medicine/Medical Oncology, Medisch Spectrum Twente, Enschede, the Netherlands

8. Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands

9. Department of Medical Oncology, University Medical Center Utrecht, Utrecht, the Netherlands

10. Department of Medical Oncology, Amsterdam UMC, location AMC, Amsterdam, the Netherlands

11. Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands

12. Department of Biostatistics, the Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, the Netherlands

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2759198/jamaoncology_steenbruggen_2020_oi_190108.pdf

Reference27 articles.

1. High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.;Berry;J Clin Oncol,2011

2. High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.;Rodenhuis;N Engl J Med,2003

3. Efficacy of high-dose alkylating chemotherapy in HER2/neu–negative breast cancer.;Rodenhuis;Ann Oncol,2006

4. Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer.;Basser;Ann Oncol,1999

5. Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy.;Cardinale;Ann Oncol,2002

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cells and Tumor-Killing Virus to Target Brain Tumor: In Pursuit to Bring a Potential Delivery Vehicle for the Central Nervous System Tumors;Current Drug Delivery;2024-01

2. Hematopoietic Cell Transplantation for Germ-Cell Tumors and Other Adult Solid Tumors;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

3. High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial;npj Breast Cancer;2023-09-09

4. Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large‐scale studies;The Journal of Pathology;2023-05-25

5. High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation;BMC Cancer;2023-01-07